Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Endocrine|June 22, 2021
Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia)Cem Haymana, Ibrahim Demirci, Ilker Tasci, et al.
Clinical Endocrinology|April 19, 2021
The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide studyMustafa Sahin, Cem Haymana, Ibrahim Demirci, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 12, 2021
Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity)Ibrahim Sahin, Cem Haymana, Tevfik Demir, et al.
Obesity Facts|March 21, 2019
Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study)Alper Sonmez, Volkan Yumuk, Cem Haymana, et al.
Internal Medicine Journal|December 23, 2021
No association of Gaucher disease with COVID-19-related outcomes: a nationwide cohort studyIbrahim Demirci, Tevfik Demir, Selcuk Dagdelen, et al.
Endokrynologia Polska|February 4, 2022
Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide studyIbrahim Demirci, Cem Haymana, Ilker Tasci, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 16, 2021
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide StudyRifat Emral, Cem Haymana, Ibrahim Demirci, et al.
Diabetes Research and Clinical Practice|March 20, 2021
Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in IstanbulIlhan Satman, Ibrahim Demirci, Cem Haymana, et al.
Primary Care Diabetes|November 25, 2025
Efficacy of synchronized diabetes monitoring system in patients with type 2 diabetes: Preliminary results of a pilot, randomized clinical trialMustafa Kahraman, Ummu Mutlu, Hasan Ediz Ozbek, et al.
Medicine|July 23, 2025
Successful treatment with rituximab of a type 2 diabetes patient with antibody-mediated insulin resistance syndrome: A case reportRamazan Çakmak, Sakin Tekin, Hülya Hacişahinoğullari, et al.
Pageof 9